Regulations.gov document
Letter to Vanda and CDER re Tradipitant
Other · FDA-2024-N-5933 · posted Oct 20, 2025
Key facts
| Document ID | FDA-2024-N-5933-0144 |
|---|---|
| Title | Letter to Vanda and CDER re Tradipitant |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2024-N-5933 |
| Posted | Oct 20, 2025 |
| Comment period opens | Oct 20, 2025 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: